» Articles » PMID: 15050959

Tumour-cell Migration, Invasion, and Metastasis: Navigation by Neurotransmitters

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2004 Mar 31
PMID 15050959
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer starts as a localised disease, which, if detected early, can often be treated successfully by removal of the primary tumour. A pernicious progression is the invasion of tumour cells into surrounding tissues, resulting in development of distant metastases. Because active migration of tumour cells is a prerequisite for tumour-cell invasion and metastasis, a pressing goal in tumour biology has been the elucidation of factors regulating the migratory activity of these cells. The most prominent regulatory factors are ligands to serpentine receptors-eg, chemokines and neurotransmitters. Many types of neurotransmitter receptors are expressed on tumour cells, supporting the theory that psychosocial factors are involved in the progression of cancer. Understanding how such receptors regulate migration and the availability of specific receptor antagonists could open up new avenues for chemoprevention of tumour-cell migration and metastatic development.

Citing Articles

Research Progress of in the Treatment of Gastrointestinal Cancer.

Wang L, Ni B, Wang J, Zhou J, Wang J, Jiang J Integr Cancer Ther. 2024; 23:15347354241302049.

PMID: 39610320 PMC: 11605761. DOI: 10.1177/15347354241302049.


Comparison between Substance P and Calcitonin Gene-Related Peptide and Their Receptors in Colorectal Adenocarcinoma.

Serban R, Boldeanu M, Florescu D, Ionescu M, Serbanescu M, Boldeanu L J Clin Med. 2024; 13(18).

PMID: 39337103 PMC: 11432560. DOI: 10.3390/jcm13185616.


Inside the Biology of the β3-Adrenoceptor.

Pasha A, Tondo A, Favre C, Calvani M Biomolecules. 2024; 14(2).

PMID: 38397396 PMC: 10887351. DOI: 10.3390/biom14020159.


Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy.

Smyth P, Ferguson L, Burrows J, Burden R, Tracey S, Herron U Front Pharmacol. 2023; 14:1296567.

PMID: 38116078 PMC: 10728302. DOI: 10.3389/fphar.2023.1296567.


The mechanisms of tanshinone in the treatment of tumors.

Zhang P, Liu W, Wang Y Front Pharmacol. 2023; 14:1282203.

PMID: 37964867 PMC: 10642231. DOI: 10.3389/fphar.2023.1282203.